Szkandera et al. could show that a common gene variant in PLS3 represents an independent prognostic marker in female patients with stage II and stage III colon cancer as the occurrence of the polymorphism was associated with a decreased time to recurrence [13]. The gene discussed is PLS3; the disease is malignant colon neoplasm.